{{Rsnum
|rsid=1947274
|Chromosome=4
|Orientation=plus
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=LPHN3
|position=61878522
|Gene_s=LPHN3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 38.3 | 55.0 | 6.7
| HCB | 48.6 | 29.7 | 21.6
| JPT | 29.3 | 51.2 | 19.5
| YRI | 16.1 | 39.3 | 44.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 48.6 | 29.7 | 21.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=25229170
|Title=Association of SNAP-25, SLC6A2, and LPHN3 With OROS Methylphenidate Treatment Response in Attention-Deficit/Hyperactivity Disorder
}}